Panel: AIFMD no cause for concern
The controversial directive will not be a game changer for private equity firms, and may even be a benefit for larger GPs, according to a panel of industry experts.
The controversial directive will not be a game changer for private equity firms, and may even be a benefit for larger GPs, according to a panel of industry experts.
Copyright PEI Media
Not for publication, email or dissemination